A Controversial Alzheimer’s Drug Has Gone Down in Flames
Cassava Sciences' simufilam failed a Phase III trial for Alzheimer's disease, likely marking the end of a drug surrounded by ...
Hosted on MSN8d
Cassava Sciences Plummets 84% After Embattled Alzheimer's Drug Flops
Cassava Sciences stock plummeted Monday — wiping out more than three-quarters of its value — after the company's Alzheimer's treatment failed in Phase 3 testing. Please watch the video at ...
EurekAlert!2y
Healthy and Diseased Cassava Plants (IMAGE)
Though cassava is easy to cultivate, it is particularly vulnerable to plant pathogens, which can significantly reduce crop yields. These images complement a paper including UC Berkeley and DOE JGI ...